5-((4-(2,6-Dioxo-1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-8-yl)oxy)-3-methoxyphenyl)-3-phenyl-4,5-dihydro-1H-pyrazole

ID: ALA3409155

PubChem CID: 118731449

Max Phase: Preclinical

Molecular Formula: C24H24N6O4

Molecular Weight: 460.49

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C2CC(c3ccccc3)=NN2)ccc1Oc1nc2c(c(=O)n(C)c(=O)n2C)n1C

Standard InChI:  InChI=1S/C24H24N6O4/c1-28-20-21(29(2)24(32)30(3)22(20)31)25-23(28)34-18-11-10-15(12-19(18)33-4)17-13-16(26-27-17)14-8-6-5-7-9-14/h5-12,17,27H,13H2,1-4H3

Standard InChI Key:  MJKDRUIDSYXTJB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 38  0  0  0  0  0  0  0  0999 V2000
    6.3703    6.6193    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4684    7.6411    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.7796    6.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4918    5.4404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0134    5.2782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1404    7.5453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3831    9.0205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7870    9.5488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.9465    8.5971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7021    7.1172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2982    6.5889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2823    3.9676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0514    2.6798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3207    1.3698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8208    1.3475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0518    2.6354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7825    3.9454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0930    0.0829    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2928    0.1024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0872    0.0382    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138   -1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.5889    0.0182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7138    1.2033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028    1.5132    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155    0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3155   -0.7475    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0028   -1.5132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2917   -0.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0907   -2.3426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9991    2.7132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3560   -1.3452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9991   -2.7132    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3560    1.3452    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
  6 11  2  0
  3  6  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 12 17  2  0
 18 19  1  0
 14 18  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 21 29  1  0
 24 29  2  0
 21 30  1  0
 25 31  1  0
 27 32  1  0
 28 33  2  0
 26 34  2  0
 20 22  1  0
 15 20  1  0
  5 12  1  0
M  END

Alternative Forms

  1. Parent:

    ALA3409155

    ---

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania panamensis (230 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 460.49Molecular Weight (Monoisotopic): 460.1859AlogP: 2.21#Rotatable Bonds: 5
Polar Surface Area: 104.67Molecular Species: NEUTRALHBA: 10HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 2.79CX LogP: 2.70CX LogD: 2.70
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.49Np Likeness Score: -0.81

References

1. Insuasty B, Ramírez J, Becerra D, Echeverry C, Quiroga J, Abonia R, Robledo SM, Vélez ID, Upegui Y, Muñoz JA, Ospina V, Nogueras M, Cobo J..  (2015)  An efficient synthesis of new caffeine-based chalcones, pyrazolines and pyrazolo[3,4-b][1,4]diazepines as potential antimalarial, antitrypanosomal and antileishmanial agents.,  93  [PMID:25725376] [10.1016/j.ejmech.2015.02.040]

Source